| Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease AB Cohen, D Lee, MD Long, MD Kappelman, CF Martin, RS Sandler, ... Digestive diseases and sciences 58, 1322-1328, 2013 | 300 | 2013 |
| Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder A McIntosh, A Cohen, N Turnbull, L Esmonde, P Dennis, J Eatock, ... Sheffield: University of Sheffield/London: National Collaborating Centre for …, 2004 | 108 | 2004 |
| Frequency and clinical correlations of granulomas in children with Crohn disease V De Matos, PA Russo, AB Cohen, P Mamula, RN Baldassano, DA Piccoli Journal of pediatric gastroenterology and nutrition 46 (4), 392-398, 2008 | 104 | 2008 |
| Silicone and polyurethane tunneled infusion catheters: a comparison of durability and breakage rates AB Cohen, M Dagli, SW Stavropoulos Jr, JI Mondschein, MC Soulen, ... Journal of Vascular and Interventional Radiology 22 (5), 638-641, 2011 | 54 | 2011 |
| Affordable Care Act (ACA) Medicaid expansion impact on racial disparities in time to cancer treatment. BJS Adamson, AB Cohen, M Estevez, K Magee, E Williams, CP Gross, ... Journal of Clinical Oncology 37 (18_suppl), LBA1-LBA1, 2019 | 53 | 2019 |
| Effectiveness of first-line immune checkpoint blockade versus carboplatin-based chemotherapy for metastatic urothelial cancer E Feld, J Harton, NJ Meropol, BJS Adamson, A Cohen, RB Parikh, ... European urology 76 (4), 524-532, 2019 | 47 | 2019 |
| Changes in vitamin D and parathyroid hormone metabolism in incident pediatric Crohn's disease AR Prosnitz, MB Leonard, J Shults, BS Zemel, BW Hollis, LA Denson, ... Inflammatory bowel diseases, 2012 | 44 | 2012 |
| Trends in checkpoint inhibitor therapy for advanced urothelial cell carcinoma at the end of life: insights from real‐world practice RB Parikh, MD Galsky, B Gyawali, F Riaz, TL Kaufmann, AB Cohen, ... The Oncologist 24 (6), e397-e399, 2019 | 39 | 2019 |
| President Trump's transgender moral panic C Pepin-Neff, A Cohen The Trump Administration, 219-234, 2022 | 27 | 2022 |
| The friends of cancer research real‐world data collaboration pilot 2.0: methodological recommendations from oncology case studies DR Rivera, HJ Henk, E Garrett‐Mayer, JB Christian, AJ Belli, ... Clinical Pharmacology & Therapeutics 111 (1), 283-292, 2022 | 27 | 2022 |
| Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2− metastatic breast cancer G Cuyun Carter, KM Sheffield, A Gossai, YJ Huang, YE Zhu, L Bowman, ... Current Medical Research and Opinion 37 (7), 1179-1187, 2021 | 23 | 2021 |
| ACA Medicaid expansion association with racial disparity reductions in timely cancer treatment. BJS Adamson, AB Cohen, CP Gross, M Estévez, K Magee, E Williams, ... American Journal of Managed Care 27 (7), 2021 | 22 | 2021 |
| Association between FDA label restriction and immunotherapy and chemotherapy use in bladder cancer RB Parikh, BJS Adamson, S Khozin, MD Galsky, SS Baxi, A Cohen, ... Jama 322 (12), 1209-1211, 2019 | 22 | 2019 |
| A phase II study of everolimus (E) and sorafenib (S) in patients (PTS) with metastatic differentiated thyroid cancer who have progressed on sorafenib alone. MS Brose, AB Troxel, M Yarchoan, AB Cohen, K Harlacker, NA Dyanick, ... Journal of Clinical Oncology 33 (15_suppl), 6072-6072, 2015 | 18 | 2015 |
| Approach to machine learning for extraction of real-world data variables from electronic health records B Adamson, M Waskom, A Blarre, J Kelly, K Krismer, S Nemeth, J Gippetti, ... Frontiers in Pharmacology 14, 1180962, 2023 | 15 | 2023 |
| Considerations for the use of machine learning extracted real-world data to support evidence generation: a research-centric evaluation framework M Estevez, CM Benedum, C Jiang, AB Cohen, S Phadke, S Sarkar, ... Cancers 14 (13), 3063, 2022 | 13 | 2022 |
| Exposure to US cancer drugs with lack of confirmed benefit after US Food and Drug Administration accelerated approval RB Parikh, RA Hubbard, E Wang, TJ Royce, AB Cohen, AS Clark, ... JAMA oncology 9 (4), 567-569, 2023 | 12 | 2023 |
| Real‐world overall survival using oncology electronic health record data: friends of cancer research pilot L Lasiter, O Tymejczyk, E Garrett‐Mayer, S Baxi, AJ Belli, M Boyd, ... Clinical Pharmacology & Therapeutics 111 (2), 444-454, 2022 | 12 | 2022 |
| First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis RB Parikh, EK Feld, MD Galsky, BJS Adamson, AB Cohen, SS Baxi, ... Future Oncology 16 (2), 4341-4345, 2020 | 12 | 2020 |
| Clinical characteristics, treatment patterns, and overall survival of real-world patients with idiopathic multicentric Castleman disease. AB Cohen, A Swaminathan, X Wang, S Zamora, MA Repucci, J Kelly, ... Journal of Clinical Oncology 39 (15_suppl), 7048-7048, 2021 | 11 | 2021 |
